guaifenesin has been researched along with HIV in 4 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "PHI-443 (N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea) is a rationally designed novel thiophene thiourea nonnucleoside reverse transcriptase inhibitor (NNRTI) with potent anti-HIV activity against the wild-type and drug-resistant primary clinical human immunodeficiency virus (HIV-1) isolates." | 3.72 | PHI-443: a novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide. ( D'Cruz, OJ; Samuel, P; Uckun, FM, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, A | 1 |
| McKinley, SA | 1 |
| Shi, F | 1 |
| Wang, S | 1 |
| Mucha, PJ | 1 |
| Harit, D | 1 |
| Forest, MG | 1 |
| Lai, SK | 1 |
| Erickson, AM | 1 |
| Henry, BI | 1 |
| Murray, JM | 1 |
| Klasse, PJ | 1 |
| Angstmann, CN | 1 |
| Myou, S | 1 |
| Zhu, X | 1 |
| Myo, S | 1 |
| Boetticher, E | 1 |
| Meliton, AY | 1 |
| Liu, J | 1 |
| Munoz, NM | 1 |
| Leff, AR | 1 |
| D'Cruz, OJ | 1 |
| Samuel, P | 1 |
| Uckun, FM | 1 |
4 other studies available for guaifenesin and HIV
| Article | Year |
|---|---|
Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A.
Topics: Agglutination; Cervix Uteri; Female; HIV; HIV Infections; Humans; Immunoglobulin A, Secretory; Model | 2015 |
Predicting first traversal times for virions and nanoparticles in mucus with slowed diffusion.
Topics: Cervix Uteri; Coitus; Computer Simulation; Diffusion; Epithelium; Female; HIV; Humans; Hydrogen-Ion | 2015 |
Blockade of airway inflammation and hyperresponsiveness by HIV-TAT-dominant negative Ras.
Topics: Administration, Intranasal; Animals; Antigens; Bronchial Hyperreactivity; Cell Migration Inhibition; | 2003 |
PHI-443: a novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide.
Topics: Absorption; Animals; Anti-Infective Agents; Biomechanical Phenomena; Cervix Uteri; Drug Stability; E | 2004 |